Coralia N. Mihu - Concepedia

Author

Coralia N. Mihu

The University of Texas MD Anderson Cancer Center

Also Known As

C Mihu, C N Mihu, C. Mihu, C.N. Mihu, CORALIA N. MIHU, Coralia Mihu, Coralia N. Mihu

Publications

961

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center The University of Texas Health Science Center at Houston

About

Coralia N. Mihu is an author at The University of Texas MD Anderson Cancer Center specializing in infection control, medicine, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	715
2	Health Sciences	3	3	672
3	Blood Transplantation	1	1	28
4	Epidemiology	1	1	28
5	Gastroenterology	1	1	16

Coralia N. Mihu

Publications

933

Citations

H-Index

Page 1

	Year	Citations
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits Katharina Brandl, George Plitas, Coralia N. Mihu, Nature Health SciencesAntibioticsInnate Immune SystemImmunologyInnate Immunity	2008	614
Incidence of Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing<i> Escherichia coli</i> at a Comprehensive Cancer Center in the United States Yogesh Bhusal, Coralia N. Mihu, Jeffrey J. Tarrand, Chemotherapy	2011	48
Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients? Coralia N. Mihu, Christelle Kassis, Elizabeth Ramos, Cancer	2010	42
Work‐up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield Mini Kamboj, Coralia N. Mihu, K. A. Sepkowitz, Transplant Infectious Disease	2007	41
Escherichia coli resistance to quinolones at a comprehensive cancer center Coralia N. Mihu, Paul R. Rhomberg, Ronald N. Jones, Diagnostic Microbiology and Infectious Disease Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2010	30
Risk factors and attributable mortality of late aspergillosis after T‐cell depleted hematopoietic stem cell transplantation Coralia N. Mihu, E. J. King, Ofer Yossepovitch, Transplant Infectious Disease	2007	30
Risk Factors for Late Staphylococcus Aureus Bacteremia after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Institution, Nested Case-Controlled Study Coralia N. Mihu, Sandra Kesh, Ann A. Jakubowski, Biology of Blood and Marrow Transplantation	2008	30
Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation Nina Cohen, Coralia N. Mihu, Susan K. Seo, Biology of Blood and Marrow Transplantation Hematologic Safety ProfileEarly Periengraftment PeriodDrug ResistanceUnderwent HsctBone Marrow Failure	2009	28
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention Amar Safdar, Gabriel Rodriguez, Coralia N. Mihu, Bone Marrow Transplantation TransplantationMarrow TransplantationMalignant Blood DisorderFungal Infection PreventionHematology	2009	27
Effect of Amphotericin B on Capsule and Cell Size in<i>Cryptococcus neoformans</i>during Murine Infection Óscar Zaragoza, Coralia N. Mihu, Arturo Casadevall, Antimicrobial Agents and Chemotherapy	2005	17

Page 1